Banco Santander (Brasil) S.A. (BVMF:SANB11)

Verve Therapeutics Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	99,647	88,916	119,724	105,138	112,480	168,302
Market Cap Growth	7.06%	-25.73%	13.87%	-6.53%	-33.17%	-8.03%
Last Close Price	26.84	22.83	29.50	24.46	24.42	32.68
PE Ratio	6.85	6.65	12.67	7.36	7.24	12.54
PS Ratio	2.00	1.88	3.08	2.52	2.40	5.41
PB Ratio	1.06	0.74	1.04	0.95	1.06	1.59
P/FCF Ratio	5.46	-	3.40	18.38	19.93	4.10
P/OCF Ratio	5.27	-	3.27	15.36	16.52	3.98
Debt / Equity Ratio	3.29	2.62	2.54	2.19	2.42	2.19
Debt / FCF Ratio	17.03	-	8.28	42.34	45.51	5.66
Return on Equity (ROE)	13.87%	11.43%	8.42%	13.24%	14.67%	13.23%
Return on Assets (ROA)	1.22%	1.14%	0.90%	1.50%	1.67%	1.59%
Earnings Yield	14.60%	15.03%	7.89%	13.59%	13.80%	7.97%
FCF Yield	18.31%	-24.58%	29.38%	5.44%	5.02%	24.41%
Dividend Yield	5.55%	3.74%	2.96%	3.91%	6.30%	1.65%
Payout Ratio	45.58%	42.04%	57.68%	51.75%	63.80%	76.61%
Buyback Yield / Dilution	-0.15%	-0.10%	-0.20%	0.44%	-0.06%	0.01%
Total Shareholder Return	5.40%	3.63%	2.76%	4.35%	6.24%	1.66%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.